"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_fax","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","supplementary_file.1","data_row_count","particle/vesicle:ch1"
"GSM617049","Normal Human BP9 EXO","GSM617049","Public on Mar 24 2011","Nov 03 2010","Mar 24 2011","RNA","1","exosome","Homo sapiens","particle/vesicle: exosome","Human Plasma","total RNA","Exosome prep (cells were removed from plasma by centrifugation for 30 min at 2,000 x g, 4°C., followed by removal of cellular debris by centrifugation of supernatant for 45 min at 12,000 x g, 4°C. Exosomes were pelleted by high-speed centrifugation 110,000 x g, 4°C for 70 min, and pellets were washed and resuspended in 1X PBS. Exosomes were depleted of lipoproteins by FPLC fractionation, and all fractions larger than LDL were collected and concentrated, Qiagen miRNAEasy Kit Total RNA isolation","","n/a","20ng of total RNA was reverse transcribed with MegaPlex RT-Pools (A&B) (43 cycles), followed by preamplification using MegaPlex PreAmp primers (pool A&B) with PreAmp Master Mix, samples were diluted 1:4 with 1X TE pH8.0 and 10uL of samples was diluted 1:100 with H2O and 2X PCR Master MIx","9606","Individual Taqman Probes & Primers, Tiled-Low Density Array","7900 Real Time PCR System","SDS 2.3 Software","GPL11155","Kasey,C,Vickers","vickerskc@nhlbi.nih.gov","301-496-5114","301-402-0190","Remaley","National Heart, Lung and Blood Institute","National Institutes of Health","10 Center Dr. Bldg. 10 8N222","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617049/suppl/GSM617049_BP9_exo_exo_Pool_A.txt.gz","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617049/suppl/GSM617049_BP9_exo_exo_Pool_B.txt.gz","666","exosome"
"GSM617050","Normal Human BP30 EXO","GSM617050","Public on Mar 24 2011","Nov 03 2010","Mar 24 2011","RNA","1","exosome","Homo sapiens","particle/vesicle: exosome","Human Plasma","total RNA","Exosome prep (cells were removed from plasma by centrifugation for 30 min at 2,000 x g, 4°C., followed by removal of cellular debris by centrifugation of supernatant for 45 min at 12,000 x g, 4°C. Exosomes were pelleted by high-speed centrifugation 110,000 x g, 4°C for 70 min, and pellets were washed and resuspended in 1X PBS. Exosomes were depleted of lipoproteins by FPLC fractionation, and all fractions larger than LDL were collected and concentrated, Qiagen miRNAEasy Kit Total RNA isolation","","n/a","20ng of total RNA was reverse transcribed with MegaPlex RT-Pools (A&B) (43 cycles), followed by preamplification using MegaPlex PreAmp primers (pool A&B) with PreAmp Master Mix, samples were diluted 1:4 with 1X TE pH8.0 and 10uL of samples was diluted 1:100 with H2O and 2X PCR Master MIx","9606","Individual Taqman Probes & Primers, Tiled-Low Density Array","7900 Real Time PCR System","SDS 2.3 Software","GPL11155","Kasey,C,Vickers","vickerskc@nhlbi.nih.gov","301-496-5114","301-402-0190","Remaley","National Heart, Lung and Blood Institute","National Institutes of Health","10 Center Dr. Bldg. 10 8N222","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617050/suppl/GSM617050_BP30_exo_exo_Pool_A.txt.gz","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617050/suppl/GSM617050_BP30_exo_exo_Pool_B.txt.gz","666","exosome"
"GSM617051","Normal Human BP32 EXO","GSM617051","Public on Mar 24 2011","Nov 03 2010","Mar 24 2011","RNA","1","exosome","Homo sapiens","particle/vesicle: exosome","Human Plasma","total RNA","Exosome prep (cells were removed from plasma by centrifugation for 30 min at 2,000 x g, 4°C., followed by removal of cellular debris by centrifugation of supernatant for 45 min at 12,000 x g, 4°C. Exosomes were pelleted by high-speed centrifugation 110,000 x g, 4°C for 70 min, and pellets were washed and resuspended in 1X PBS. Exosomes were depleted of lipoproteins by FPLC fractionation, and all fractions larger than LDL were collected and concentrated, Qiagen miRNAEasy Kit Total RNA isolation","","n/a","20ng of total RNA was reverse transcribed with MegaPlex RT-Pools (A&B) (43 cycles), followed by preamplification using MegaPlex PreAmp primers (pool A&B) with PreAmp Master Mix, samples were diluted 1:4 with 1X TE pH8.0 and 10uL of samples was diluted 1:100 with H2O and 2X PCR Master MIx","9606","Individual Taqman Probes & Primers, Tiled-Low Density Array","7900 Real Time PCR System","SDS 2.3 Software","GPL11155","Kasey,C,Vickers","vickerskc@nhlbi.nih.gov","301-496-5114","301-402-0190","Remaley","National Heart, Lung and Blood Institute","National Institutes of Health","10 Center Dr. Bldg. 10 8N222","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617051/suppl/GSM617051_BP32_exo_exo_Pool_A.txt.gz","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617051/suppl/GSM617051_BP32_exo_exo_Pool_B.txt.gz","666","exosome"
"GSM617052","Normal Human BP9 HDL","GSM617052","Public on Mar 24 2011","Nov 03 2010","Mar 24 2011","RNA","1","HDL","Homo sapiens","particle/vesicle: HDL","Human Plasma","total RNA","HDL,3-step purifcation (DGUC,FPLC,IP),Qiagen miRNAEasy Kit","HDL was isolated from human plasma by density-gradient ultracentrifugation (d=1.063-1.21g/mL), followed by fast-protein liquid chromatography (FPLC), and anti-Apo-AI immunoprecipitation (HDL-IP)","n/a","20ng of total RNA was reverse transcribed with MegaPlex RT-Pools (A&B) (43 cycles), followed by preamplification using MegaPlex PreAmp primers (pool A&B) with PreAmp Master Mix, samples were diluted 1:4 with 1X TE pH8.0 and 10uL of samples was diluted 1:100 with H2O and 2X PCR Master MIx","9606","Individual Taqman Probes & Primers, Tiled-Low Density Array","7900 Real Time PCR System","SDS 2.3 Software","GPL11155","Kasey,C,Vickers","vickerskc@nhlbi.nih.gov","301-496-5114","301-402-0190","Remaley","National Heart, Lung and Blood Institute","National Institutes of Health","10 Center Dr. Bldg. 10 8N222","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617052/suppl/GSM617052_BP9_Pool_A.txt.gz","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617052/suppl/GSM617052_BP9_Pool_B.txt.gz","666","HDL"
"GSM617053","Normal Human BP30 HDL","GSM617053","Public on Mar 24 2011","Nov 03 2010","Mar 24 2011","RNA","1","HDL","Homo sapiens","particle/vesicle: HDL","Human Plasma","total RNA","HDL,3-step purifcation (DGUC,FPLC,IP),Qiagen miRNAEasy Kit","HDL was isolated from human plasma by density-gradient ultracentrifugation (d=1.063-1.21g/mL), followed by fast-protein liquid chromatography (FPLC), and anti-Apo-AI immunoprecipitation (HDL-IP)","n/a","20ng of total RNA was reverse transcribed with MegaPlex RT-Pools (A&B) (43 cycles), followed by preamplification using MegaPlex PreAmp primers (pool A&B) with PreAmp Master Mix, samples were diluted 1:4 with 1X TE pH8.0 and 10uL of samples was diluted 1:100 with H2O and 2X PCR Master MIx","9606","Individual Taqman Probes & Primers, Tiled-Low Density Array","7900 Real Time PCR System","SDS 2.3 Software","GPL11155","Kasey,C,Vickers","vickerskc@nhlbi.nih.gov","301-496-5114","301-402-0190","Remaley","National Heart, Lung and Blood Institute","National Institutes of Health","10 Center Dr. Bldg. 10 8N222","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617053/suppl/GSM617053_BP30_Pool_A.txt.gz","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617053/suppl/GSM617053_BP30_Pool_B.txt.gz","666","HDL"
"GSM617054","Normal Human BP32 HDL","GSM617054","Public on Mar 24 2011","Nov 03 2010","Mar 24 2011","RNA","1","HDL","Homo sapiens","particle/vesicle: HDL","Human Plasma","total RNA","HDL,3-step purifcation (DGUC,FPLC,IP),Qiagen miRNAEasy Kit","HDL was isolated from human plasma by density-gradient ultracentrifugation (d=1.063-1.21g/mL), followed by fast-protein liquid chromatography (FPLC), and anti-Apo-AI immunoprecipitation (HDL-IP)","n/a","20ng of total RNA was reverse transcribed with MegaPlex RT-Pools (A&B) (43 cycles), followed by preamplification using MegaPlex PreAmp primers (pool A&B) with PreAmp Master Mix, samples were diluted 1:4 with 1X TE pH8.0 and 10uL of samples was diluted 1:100 with H2O and 2X PCR Master MIx","9606","Individual Taqman Probes & Primers, Tiled-Low Density Array","7900 Real Time PCR System","SDS 2.3 Software","GPL11155","Kasey,C,Vickers","vickerskc@nhlbi.nih.gov","301-496-5114","301-402-0190","Remaley","National Heart, Lung and Blood Institute","National Institutes of Health","10 Center Dr. Bldg. 10 8N222","Bethesda","MD","20892","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617054/suppl/GSM617054_BP32_Pool_A.txt.gz","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM617nnn/GSM617054/suppl/GSM617054_BP32_Pool_B.txt.gz","666","HDL"
